Russell HV - Search Results

1

Inpatient versus outpatient vincristine, dactinomycin, and cyclophosphamide for pediatric cancers: Quality and cost implications.

Beaty RS, Bernhardt MB, Berger AH, Hesselgrave JE, Russell HV, Okcu MF. Beaty RS, et al. Among authors: russell hv. Pediatr Blood Cancer. 2015 Nov;62(11):1925-8. doi: 10.1002/pbc.25610. Epub 2015 Jul 7. Pediatr Blood Cancer. 2015. PMID: 26152314

2

CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.

Russell HV, Hicks J, Okcu MF, Nuchtern JG. Russell HV, et al. J Pediatr Surg. 2004 Oct;39(10):1506-11. doi: 10.1016/j.jpedsurg.2004.06.019. J Pediatr Surg. 2004. PMID: 15486895

3

Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow.

Okcu MF, Wang RY, Bueso-Ramos C, Schober W, Weidner D, Andrassy R, Blakely M, Russell H, Ozkan A, Kuttesch J, Andreeff M, Chan KW, Ater J. Okcu MF, et al. Pediatr Blood Cancer. 2005 Nov;45(6):787-95. doi: 10.1002/pbc.20428. Pediatr Blood Cancer. 2005. PMID: 15929127

4

The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.

Russell HV, Golding LA, Suell MN, Nuchtern JG, Strother DR. Russell HV, et al. Pediatr Blood Cancer. 2005 Dec;45(7):916-9. doi: 10.1002/pbc.20520. Pediatr Blood Cancer. 2005. PMID: 16078212

5

Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma.

Vasudevan SA, Russell HV, Okcu MF, Burlingame SM, Liu ZJ, Yang J, Nuchtern JG. Vasudevan SA, et al. Among authors: russell hv. J Pediatr Surg. 2007 Jan;42(1):148-52. doi: 10.1016/j.jpedsurg.2006.09.064. J Pediatr Surg. 2007. PMID: 17208556

6

Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy.

Russell H, Hicks MJ, Bertuch AA, Chintagumpala M. Russell H, et al. Pediatr Blood Cancer. 2009 Jul;53(1):23-7. doi: 10.1002/pbc.21981. Pediatr Blood Cancer. 2009. PMID: 19340853

7

Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma.

Shang X, Burlingame SM, Okcu MF, Ge N, Russell HV, Egler RA, David RD, Vasudevan SA, Yang J, Nuchtern JG. Shang X, et al. Among authors: russell hv. Mol Cancer Ther. 2009 Aug;8(8):2461-9. doi: 10.1158/1535-7163.MCT-08-0857. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671766 Free PMC article.

8

Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma.

Shang X, Vasudevan SA, Yu Y, Ge N, Ludwig AD, Wesson CL, Wang K, Burlingame SM, Zhao YJ, Rao PH, Lu X, Russell HV, Okcu MF, Hicks MJ, Shohet JM, Donehower LA, Nuchtern JG, Yang J. Shang X, et al. Among authors: russell hv. Oncogene. 2010 Sep 2;29(35):4938-46. doi: 10.1038/onc.2010.244. Epub 2010 Jun 21. Oncogene. 2010. PMID: 20562916 Free PMC article.

9

Refractory dilated cardiomyopathy associated with metastatic neuroblastoma.

Carlson P, Jefferies JL, Kearney D, Russell H. Carlson P, et al. Pediatr Blood Cancer. 2010 Oct;55(4):736-8. doi: 10.1002/pbc.22569. Pediatr Blood Cancer. 2010. PMID: 20589652

10

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.

Russell HV, Groshen SG, Ara T, DeClerck YA, Hawkins R, Jackson HA, Daldrup-Link HE, Marachelian A, Skerjanec A, Park JR, Katzenstein H, Matthay KK, Blaney SM, Villablanca JG. Russell HV, et al. Pediatr Blood Cancer. 2011 Aug;57(2):275-82. doi: 10.1002/pbc.22821. Epub 2010 Nov 12. Pediatr Blood Cancer. 2011. PMID: 21671363 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters